A Phase I, Placebo-Controlled, Randomized, Double-Blind, Single Ascending Dose-Ranging Study to Evaluate the Safety and Tolerability of a Novel Biophysical Bronchodilator (S-1226) Administered by Nebulization in Healthy Volunteers

Trials - United Kingdom
doi 10.1186/s13063-016-1489-8